FRI545 Durability Of Treatment Response With VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor, In Patients With Thyroid Eye Disease (TED): Phase 1/2 Clinical Study Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Douglas, Raymond
  • Ugradar, Shoaib
  • Cockerham, Kimberley
  • Turbin, Roger Eric
  • Tang, Rosa
  • Nijhawan, Navdeep
  • O’Shaughnessy, Denis J
  • Summerfelt, Rochelle M
  • She, Angela
  • Katz, Barrett

publication date

  • October 5, 2023